Osivax today announced that it has received a grant of over $1.5 million from the U.S. National Institute of Allergy and Infectious Diseases (NIAID). The grant will support preclinical studies evaluating the breadth of protection and... READ →
Precision Vaccinations
/ December 5th, 2023Eliminating fake vaccine news with pharmacist, nurse, and physician review.
For more articles, try our search.